Six findings in one retail pharmacy inspection
An inspector visits a retail pharmacy in Pune and records: (i) 40 strips of a third-generation cephalosporin (Schedule H1) with no corresponding entry in the Schedule H1 register; (ii) the register exists but its oldest entry is 8 months old and 12 entries lack the prescriber's name and registration number; (iii) three packs of a Schedule X sedative are kept on the open dispensing shelf; (iv) the pharmacy's registration certificate expired 12 days ago and the renewal application was filed only on the day of inspection; (v) the registered pharmacist leaves at 6 pm and a trained 'compounder' has been dispensing after 6 pm for the past three weeks; (vi) expired tablets sit in a labelled bin in the back room but have not been destroyed or returned and remain in the sales area. The owner argues that the pharmacy is '99% compliant' and that the inspector cannot take action because the renewal has been filed.
1. Classify each finding under the Drugs and Cosmetics Act and Rules and rank them by regulatory seriousness. Which findings could lead to suspension or cancellation of the licence rather than prosecution?
Read the worked answer
Rank by what the law treats as most serious and by what can harm a patient. First, (iv): a registration certificate that expired 12 days ago means every sale since then was made without a valid licence - an offence of sale without licence and a ground for suspension or cancellation of the retail licence under the rules. Suspension is the immediate regulatory consequence; prosecution is possible. Second, (v): dispensing by an unregistered 'compounder' with no registered pharmacist on the premises breaches the condition that compounding and dispensing be done by a registered pharmacist, attracts Chapter IV penalties, and is the finding most likely to harm a patient, because nobody with pharmacological training is checking prescriptions and doses. Third, (iii): a Schedule X drug on an open shelf breaches the storage and record conditions - locked cupboard, separate prescription file, prescriptions in duplicate retained - which exist because of dependence liability. Fourth, (i) and (ii): the Schedule H1 register is incomplete and missing prescriber details, a breach of the Schedule H1 conditions; serious but administrative and correctable. Fifth, (vi): holding expired stock is not itself an offence if it is clearly segregated, but any sale of it would be, and failure to destroy it is a compliance failure.
The '99% compliant' characterisation is irrelevant: each dispensed medicine is a separate transaction, and the finding most likely to attract suspension is the expired licence. The exact penalty provision and quantum should be checked against the current Act and Rules before the inspection report is finalised.
2. Address the owner's two arguments: the renewal application and the 'compounder' dispensing after 6 pm. What must happen before the pharmacy dispenses again?
Read the worked answer
The renewal argument fails. A licence that has expired is not revived by an application filed afterwards; until the licensing authority renews it the pharmacy is not licensed and must not sell or distribute drugs. The owner should stop dispensing immediately, quarantine and secure the stock, apply for renewal with the prescribed fee and any late fee, and reopen only when the renewed certificate is in hand. Sales made in the gap remain unauthorised and should be disclosed rather than concealed.
The 'compounder' argument fails too. A trained assistant may help with billing, stocking and handing over a prepared medicine, but compounding and dispensing must be done, or directly supervised, by a registered pharmacist whose registration is current and who is present on the premises. If the shop cannot staff a pharmacist after 6 pm, the shop must close at 6 pm.
A pre-reopening checklist: valid registration certificate; valid pharmacist registration; the pharmacist physically present for all dispensing hours, with a written roster; the Schedule H1 register and Schedule X cupboard restored; expired stock segregated and booked for destruction; and a written undertaking to the inspector. Documenting the corrective action matters as much as taking it, because the next inspection tests whether the system changed, not whether promises were made.
3. Write the SOP-level corrective actions: Schedule H1 and Schedule X record-keeping specifics, expired stock handling, and a monthly self-audit checklist.
Read the worked answer
The SOP has to make the right action the easy action. For Schedule H1 drugs: a separate, bound, serially numbered register with date of sale, name and quantity of the drug, batch number, patient name and address, and prescriber name and registration number; retained for three years and available for inspection; and packs labelled with the Rx symbol in a red box warning that they are not to be sold without a prescription. For Schedule X: storage in a locked cupboard with the key held by the registered pharmacist, prescriptions in duplicate kept in a separate file for two years, and a running account of receipts and issues.
For expired stock: a labelled 'Expired - not for sale' container outside the dispensing area, an entry in a disposal register with batch and quantity, destruction by an authorised route (return to supplier or incineration) with a certificate, and never a return to the general shelf.
The monthly self-audit should cover licence and pharmacist registration validity (renew at least three months before expiry), a roster showing a pharmacist on the premises for every open hour, spot checks of ten random prescriptions against register entries, refrigerator and cold-chain temperature logs, storage segregation, and a signed review by the responsible pharmacist. Any failed item should be escalated to the owner in writing within 48 hours.